100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Samenvatting Spijsvertering (Laleman) $8.56
Add to cart

Summary

Samenvatting Spijsvertering (Laleman)

1 review
 95 views  7 purchases
  • Course
  • Institution

Dit document bevat de leerstof van prof. Laleman voor het vak 'spijsvertering' van de 1e master. Het is gebaseerd op de slides van in de lessen.

Preview 6 out of 58  pages

  • January 17, 2024
  • 58
  • 2023/2024
  • Summary

1  review

review-writer-avatar

By: camillelauwers • 3 weeks ago

avatar-seller
INHOUD

Deel prof Laleman .................................................................................................................................................. 4
Hoofdstuk 1: acute leverziekten ............................................................................................................................. 4
Inleiding ............................................................................................................................................................... 4
Levertesten ......................................................................................................................................................... 5
Bilirubine ......................................................................................................................................................... 5
Aspartaat aminotransferase (AST) .................................................................................................................. 5
Alanine aminotransferase (ALT) ...................................................................................................................... 5
Lactaat dehydrogenase (LDH) ......................................................................................................................... 5
Alkalisch fosfatase (AF) ................................................................................................................................... 6
Gamma glutamyl transpeptidase (GGT) .......................................................................................................... 6
Protrombine tijd (PT, INR) ............................................................................................................................... 6
Albumine ......................................................................................................................................................... 6
Technische onderzoeken..................................................................................................................................... 6
Acute hepatitis .................................................................................................................................................... 8
Symptomen ..................................................................................................................................................... 8
Biochemische afwijkingen ............................................................................................................................... 8
Oorzaken ......................................................................................................................................................... 8
Hepatitis A (HAV) – infectieus viraal hepatotroop ...................................................................................... 9
Hepatitis B (HBV) – infectieus viraal hepatotroop .................................................................................... 10
Hepatitis D (delta) – infectieus viraal hepatotroop ................................................................................... 11
Hepatitis C (HCV) – infectieus viraal hepatotroop .................................................................................... 11
Hepatitis E (HEV) – infectieus viraal hepatotroop ..................................................................................... 12
Gele koorts virus – infectieus viraal niet-hepatotroop ............................................................................. 12
Brucellose – infectieus niet-viraal ............................................................................................................. 13
leptospirosis – infectieus niet-viraal ......................................................................................................... 13
Q-fever – infectieus niet-viraal.................................................................................................................. 13
DILI – toxisch ............................................................................................................................................. 14
Acuut leverfalen ............................................................................................................................................ 16
Hoofdstuk 2: chronische leverziekten ................................................................................................................... 17
Schade evalueren .............................................................................................................................................. 17
Symptomen ....................................................................................................................................................... 17
Oorzaken ....................................................................................................................................................... 18
Hepatitis B (HBV) – infectieus viraal .......................................................................................................... 18
Hepatitis D (delta) – infectieus viraal hepatotroop ................................................................................... 19
Hepatitis C (HCV) – infectieus viraal hepatotroop .................................................................................... 20



Inhoud 1

, Hepatitis E (HEV) – infectieus viraal hepatotroop ..................................................................................... 20
Chronische auto-immune hepatitis – inflammatoir .................................................................................. 21
Inleiding – cholestatisch ............................................................................................................................ 22
Primaire biliaire cholangitis (PBC) – cholestatisch .................................................................................... 22
Primaire scleroserende cholangitis (PSC) – cholestatisch ......................................................................... 23
Hemochromatose – metabool .................................................................................................................. 24
Ziekte van Wilson – metabool ................................................................................................................... 25
Alfa-1-antitrypsine deficiëntie (A1AT) – metabool ................................................................................... 26
Metabolic dysfunction associated steatotic liver disease (MASLD) – steatotic liver disease (SLD) .......... 27
Alcohol associated steatotic liver disease (ALD) – steatotic liver disease (SLD) ....................................... 28
Alcoholische steatohepatitis (ASH) – steatotic liver disease (SLD) ........................................................... 30
Metabolic dysfunction and alcohol intake (combinatie: MetALD) – steatotic liver disease (SLD) ............ 31
Specific aetiology SLD – steatotic liver disease (SLD) ................................................................................ 31
Cryptogene SLD – steatotic liver disease (SLD) ......................................................................................... 31
Hoofdstuk 3: cirrose en complicaties .................................................................................................................... 32
Cirrose ............................................................................................................................................................... 32
Oorzaken ....................................................................................................................................................... 32
Symptomen ................................................................................................................................................... 33
Technische onderzoeken............................................................................................................................... 33
Behandeling .................................................................................................................................................. 33
Complicaties door portale hypertensie ............................................................................................................. 34
Gastro-oesofagale varices bloeding .............................................................................................................. 34
Congestieve gastropathie – gastrisch antrale vasculaire ectasie (GAVE) ...................................................... 36
Ascites ........................................................................................................................................................... 36
Hepatorenaal syndroom ............................................................................................................................... 38
Hepatopulmonaal syndroom ........................................................................................................................ 38
Portopulmonaire hypertensie ....................................................................................................................... 39
Complicaties door leverinsufficiëntie................................................................................................................ 39
Hepatische encefalopathie............................................................................................................................ 39
Acuut op chronisch leverfalen (ACLF) ............................................................................................................... 41
Hoofdstuk 4: benigne aandoeningen van de pancreas ......................................................................................... 42
Anatomie pancreas ........................................................................................................................................... 42
Fysiologie pancreas ........................................................................................................................................... 42
Evaluatie pancreasschade en -functie ............................................................................................................... 43
Benigne aandoeningen van pancreas ............................................................................................................... 43
Congenitale pancreas pathologie .................................................................................................................. 43
Pancreas divisum....................................................................................................................................... 43


Inhoud 2

, Pancreas annulare ..................................................................................................................................... 44
Acute pancreatitis ......................................................................................................................................... 44
Chronische pancreatitis................................................................................................................................. 47
Hoofdstuk 5: vasculaire aandoeningen van de lever ............................................................................................ 50
Vasculaire anatomie van de lever ..................................................................................................................... 50
Vasculaire aandoeningen van de lever ............................................................................................................. 50
Vena porta trombose .................................................................................................................................... 50
Syndroom van Budd-Chiari (BCS) .................................................................................................................. 51
Sinusoïdaal obstructie syndroom (SOS) ........................................................................................................ 52
Ziekte van Rendu-Osler-Weber (hereditaire hemorragische teleangiëctasie – HHT) ................................... 52
Porto-sinusoïdaal vasculaire stoornis (PSVD) ................................................................................................ 53
Hoofdstuk 6: zwangerschap en leverziekte .......................................................................................................... 54
Leverproblemen in de zwangerschap ............................................................................................................... 54
Hyperemesis gravidarum .............................................................................................................................. 54
Intrahepatic cholestasis of pregnancy (ICP) .................................................................................................. 55
HELLP syndroom............................................................................................................................................ 55
Acute fatty liver of pregnancy ....................................................................................................................... 56
Hoofdstuk 7: icterus .............................................................................................................................................. 57
Vormen en oorzaken van icterus ...................................................................................................................... 57
Stappenplan diagnose ....................................................................................................................................... 57




Inhoud 3

,DEEL PROF LALEMAN
HOOFDSTUK 1: ACUTE LEVERZIEKTEN

INLEIDING

Opbouw van de lever

- Lever < 4 lobben
o Lobus quadratus
o Lobus caudatus
o Lobus dextra
o Lobus sinistra
o Anterior: ligamentum falciforme -> ligamentum teres
- Lever < 8 segmenten → belangrijk voor chirurgie (segmentectomie)

Biliaire anatomie

- Gal: 600 ml/dag
- Intrahepatische galcanaliculi -> d hepaticus -> d choledochus (+ d cysticus uitmonden) -> duodenum
thv papil van Vater

Functies van de lever

1. Synthese
• Eiwitten
• Lokaal binden
• Lokaal enzymatisch
• Exportproteïnen (albumine, stollingseiwitten, glyco- en lipoproteïnen)
• Koolhydraten
• Glucose laatste voeding (1-2u)
• Glycogeen reserve (4-12u)
• Ketonen via vetzuuroxidatie (3-4u)
• Gluconeogenese (aanmaak glucose uit AZ)
• Cholesterol en triglyceriden
• Galzuren en hormonen
2. Afbraak
• Xenobiotica en toxines
• Ureum cyclus (NH3)
• Bilirubine
• Glycogenolyse (glycogeen afgebroken tot glucose)
• => wateroplosbaar maken en excreteren via gal, stoelgang
3. Stockeren
• Glycogeen (100 g)
• Vitamine A, D, E, K, B12
• Ijzer (ferritine)
• Koper
4. Immunologisch
• Aangeboren (innate) en verworven (adaptive) immuniteit
• Tolerantie
• Cytokineproductie en regulatie



Deel prof Laleman 4

,Functie van gal

- Emulgeren vetten tot micellen
- Hulp bij absorptie van vetoplosbare vitamines (A, D, E, K)
- Excretie van afvalstoffen (bilirubine)
- Bufferen maagzuur (alkalische pH 7,5-8)
- Bacteriostatisch/bactericide werking (IgA)

LEVERTESTEN

Geen functie testen

- Synthese functie: PT, albumine
- Excretie functie: totaal bilirubine, ammoniak
- Hepatocellulaire necrose: AST, ALT, LDH
- Cholestase: alkalisch fosfatase (AF), GGT
 Nooit op zichzelf interpreteren, wel in gebruik van klinische context
 Aanvullen met anamnese en KO


BILIRUBINE
RBC -> Hb -> globine + heem -> bilirubine (ongeconjugeerd, binden aan albumine) -> bilirubine (geconjugeerd,
in lever) -> urine, faeces

Problemen

- Hemolyse (afbraak RBC tot Hb)
- Competitie met binding albumine
- Conjugatiestoornis of leverceldysfunctie (geen °geconjugeerd bilirubine)
- Galwegobstructie (problemen afvoer)


ASPARTAAT AMINOTRANSFERASE (AST)
- Productie AST in hart, spieren, lever (lager thv: hersenen, RBC, pancreas, nieren)
- Lektest: weefselschade -> vrijkomen AST (bloed)
o Myocardinfarct, rhabdomyolyse, spierdystrofie, hemolyse
o Hepatitis, ischemie, hepatotoxiciteit
 Niet per se leverprobleem!


ALANINE AMINOTRANSFERASE (ALT)
- Productie ALT in lever (lager thv: hart, spieren, nieren)
- Lektest: weefselschade -> vrijkomen ALT (in bloed)
o Myocardinfarct, rhabdomyolyse, spierdystrofie, hemolyse
o Hepatitis, ischemie, hepatotoxiciteit, galwegobstructie
 Meer leverspecifiek dan AST


LACTAAT DEHYDROGENASE (LDH)
- Productie LDH in hart, spieren, lever, hersenen, RBC, nieren
- Lektest: weefselschade -> vrijkomen LDH (in bloed)
o Vnl context ischemie
 Niet leverspecifiek!


Hoofdstuk 1: acute leverziekten 5

, ALKALISCH FOSFATASE (AF)
- Productie AF in lever, botten, placenta
- Indien op zichzelf gestegen (geïsoleerd) → bot, placenta nakijken (bv zwangerschap)
- Indien gestegen + GGT → cholestase
o Intra- of extrahepatisch
o Compressie, obstructie, infiltratie
o Zien na 24 u


GAMMA GLUTAMYL TRANSPEPTIDASE (GGT)
- Productie GGT in lever (lager thv: hart, nieren, darmen)
- Indien gestegen + AF → cholestase
- GGT/AF > 2,5 → suggestief voor EtOH
- Kan ook stijgen bij: anticonceptiepil, steatose


PROTROMBINE TIJD (PT, INR)
- Productie stollingsfactoren in lever
- Merker voor acute leverziekten!
- Kan ook dalen bij: hypovitaminose K, anticoagulantia, hemofilie, DIC
 Beste lever ‘functie’ test!


ALBUMINE
- Productie albumine in lever (hepatocyten -> 10 g/dag)
- Merker voor chronische leverziekten!
- Kan ook dalen bij: malnutritie, nefrotisch syndroom, protein-losing enteropathy

Functies

- Oncotische druk
- Oplosbaarheid, transport, metabolisme
- Anti-oxidant
- Immunomodulatie
- Endotheliale stabilisatie
- Hemostatische effecten
- Capillaire permeabiliteit

TECHNISCHE ONDERZOEKEN
Echo abdomen CT abdomen

- Geen RX stralen (+) - Morfologie (+)
- Vlot beschikbaar (+) - Vascularisatie (+)
- Goedkoop (+) - 3 fasen (+)
- Snel (+) - Snel (+)
- Operator-dependent (-) - RX stralen (-)
- Redelijk duur (-)
- Contrast -> allergie (-)




Hoofdstuk 1: acute leverziekten 6

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller zGNK. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $8.56. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

53022 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$8.56  7x  sold
  • (1)
Add to cart
Added